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Diclofenac sodium (DS) and diacerein (DC) have emerged as a potential combination therapy for 
the treatment of knee osteoarthritis. Therefore a validated analytical method is essential for the 
simultaneous estimation of both from combined dosage form. A ratio derivative spectrophotometric and 
a chromatographic technique have been developed for the simultaneous determination of DS and DC. 
The quantification was done at 263.00 nm for DC and 304.50 nm for DS in the first method, whereas 257 
nm for DC and at 274 nm for DS for LC-DAD analysis in chromatographic method using acetate buffer 
and methanol as the mobile phase at a flow-rate 0.50 mL/min. Both of these methods are found to be 
linear in the concentration range under study with r2 value 0.999 and 0.996 for DS and DC respectively 
in ratio derivative spectroscopy and 0.998 and 0.999 for DS and DC respectively in LC-DAD study. 
Both of these methods are found to be accurate and precise, though greater robustness and precision is 
observed with chromatographic analysis over the ratio derivative spectroscopy. Statistically there was 
no significant difference between proposed ratio derivative spectrophotometric and LC-DAD methods.
Uniterms: Diacerein/comparative study. Diclofenac sodium/comparative study. High Pressure Liquid 
Chromatography. LC-DAD. Ratio derivative spectroscopy/validation
INTRODUCTION
Diacerein (DC), chemically 4,5-diacetoxy-9,10-
dihydro-9,10-dioxo-2- anthracenecarboxylic acid 
(Figure 1A), is an anti-osteoarthritic (Bartelsyz et al., 
2010; Fidelix et al., 2014) drug usually prescribed for 
the treatment of symptomatic osteoarthritis of knee 
(Louthrenoo et al., 2007; Zheng et al., 2006). It is a purified 
anthraquinone and on absorption it is entirely transformed 
into rhein, an active metabolite found in plasma and 
synovial fluid. DC defines a new class of anti-osteoarthritic 
drug known as “disease modifying osteoarthritis drug” 
(DMOAD) or “chemoprotective agent” (Verbruggen, 
2006; Pelletier, Martel-Pelletier, 2007). It is found to have 
novel anti-inflammatory properties different from classical 
nonsteroidal anti-inflammatory agents that support its use 
in combination with nonsteroidal anti-inflammatory drugs 
(NSAID) for the treatment of osteoarthritis including 
rheumatoid osteoarthritis (Tamura et al., 2002). Recently 
it has been found to reduce visceral pain through inhibition 
of glutamatergic neurotransmission and cytokine signaling 
in mice (Gadotti et al., 2012).
Diclofenac sodium (DS) chemically sodium salt 
of 2-(2-(2,6-dichlorophenylamino)phenyl) acetic acid 
(Figure 1B), is a NSAID commonly prescribed for the relief 
of musculoskeletal disorders like joint pains, osteoarthritis 
FIGURE 1 - Chemical structure of diacerein (A) and diclofenac 
sodium (B).
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and rheumatoid arthritis, inflammations, soft tissue 
disorders like sprains and several other pathophysiological 
conditions like acute gout, dysmenorrhea, migraine and 
even after certain surgical procedures (Zhang et al., 2014).
A recent report presents that the use of DC as 
an adjuvant to DS improves the therapeutic profile in 
osteoarthritic knee compared to DS alone (Singh, Sharma, 
Rai, 2012). Thus a combination of these two drugs forms 
a newer therapeutic regimen. Here in lies the need for 
the development of validated and sensitive analytical 
procedures for the simultaneous estimation of both DC 
and DS from such formulations. 
The ratio derivative spectrophotometry (RDS) is a 
good analytical technique of great utility for extracting 
quantitative information from spectra of unresolved 
bands. In this RDS method the zero-order spectrum for 
a mixture is divided by the divisor standard spectra of 
each analyte followed by derivatization and hence the 
spectrum becomes independent of the other analyte 
concentration. The use of standardized spectra as divisors 
minimizes experimental errors and background noise. 
Easy measurements of separate peaks, higher values of 
the analytical signals are advantages of ratio derivative 
spectrophotometry. The presence of a lot of maxima 
and minima in ratio derivative spectra seems to be 
advantageous for the method, since these wavelengths give 
an opportunity for the determination of these compounds 
in the presence of other active compounds and excipients 
that may interfere.
High Pressure Liquid Chromatography (HPLC) 
is used in analytical chemistry or biochemistry to 
separate chemical compounds in mixtures for analysis or 
purification or quantification from a binary mixture. In 
this method the sample mixture is pressurized through a 
column filled with a solid adsorbent material, where each 
component in the sample interacts slightly differently with 
the adsorbent material, causing different flow rates for the 
different components and leading to the separation of the 
components as they flow out the column.
The review of the literature showed the presence 
of both spectrophotometric methods (Baghel, Dhiman, 
2012; Nebsen et al., 2011; Pandey et al., 2012; Sivakumar 
et al., 2010) and chromatographic techniques (Ali et al., 
2014; Ashok et al., 2009; Hamrapurkar et al., 2011; Patel 
et al., 2014; Sivakumar et al., 2010) for the estimation of 
DC from different formulations in presence of NSAIDs 
(Baghel, Dhiman, 2012), impurities (Ashok et al., 2009) 
and its corresponding metabolites from human serum 
(Ojha, Rathod, Padh, 2009). For the quantification of DS 
the pharmacopoeias present its non-aqueous titration in 
bulk forms and chromatographic procedures for various 
formulations (Dahivelkar et al., 2012). Other techniques 
include mainly spectrophotometric (Botello, Perez-
Caballero, 1995) and chromatographic procedures (Abdel-
Hamid, Novotny, Hamza, 2001; Carreira et al., 1995; Ji, 
Zhan, 2000; Kaale et al., 2013; Thongchai et al., 2006) for 
analyzing the drugs individually.
However, extensive literature survey fails to 
present a rapid and selective spectroscopic analysis 
and chromatographic procedure for the simultaneous 
estimation of both these drugs from their combined 
dosage form. In the current study we present a simple, 
rapid, sensitive and validated spectroscopic method and 
a precise and validated chromatographic procedure based 
on LC-DAD technique for the estimation of both of these 
drugs in combined dosage from.
MATERIAL AND METHODS
Material
Diacerein (DC) was procured from Biogen Extracts 
Pvt. Ltd. (Bangalore, India) and diclofenac sodium (DS) 
was obtained as a gift sample from Dey’s Medical Stores 
(Mfg.) Ltd. (Kolkata, India), Carbopol 934 (CDH) and 
triethanolamine (Merck) were purchased from local 
supplier. HPLC grade solvents like acetonitrile, methanol 
and water were purchased from Spectrochem India Ltd. 
All other salts and reagents were of guaranteed reagent 
grade and were purchased from Merck India Ltd. A C18 
column 250 mm x 4.6 mm (Atlantis T3) was purchased 
from Water’s Corporation (Millford, USA).
Methods
Preparation of drug loaded transdermal gel
The gel was prepared by dispersing 500 mg of 
carbopol in definite amount of water very slowly with 
constant stirring. Then drug solution (3.5 mg/mL of each 
in water) was added, followed by 2.5 g chloroform and 
distilled water to make the 25 g gel. The pH of the gel was 
brought to skin pH by adding 500 mg triethanolamine. 
During pH adjustment, the mixture was stirred gently 
until the formation of homogeneous gel. The product was 
allowed to stand for 24 hours at room temperature before 
further studies (Karade et al., 2012).
Procedure for ratio derivative spectroscopy
A series of solutions in the concentration range 
1 µg/mL to 10 µg/mL were obtained from respective 
stock solutions prepared in phosphate buffer pH 7.4. The 
absorption spectra were recorded between 200 nm to 600 
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nm for standard and sample solutions against phosphate 
buffer (pH 7.4) as blank.
For sample solution, 1.0 g of the transdermal gel 
preparation was accurately weighed and transferred to a 
50ml volumetric flask. 30 ml of the buffer pH 7.4 and 5 
mL of methanol were added and the mass was sonicated 
for 1hr, allowed to cool to room temperature and the final 
volume was made up with the buffer. It was centrifuged at 
8000 rpm for 25 minutes and the supernatant was diluted 
suitably to obtain a final concentration of 20 µg/mL for 
both DC and DS.
A study of variables like concentration of the standard 
spectrum divisor, number of points for the smoothing 
function and Δλ were necessary for the simultaneous 
determination of DS and DC using first derivative ratio 
spectroscopy in order to optimize the signal of the ratio 
derivative spectra with good selectivity and higher 
sensitivity (Rote, Bari, 2009). Concentrations of 5µg /mL 
of DC (DC5) and 6 µg /ml of DS (DS6) were selected as 
divisor concentration. The divisor concentration was chosen 
to minimize the background noise and experimental error. 
The saved spectrums of DC were divided with spectra of 
selected DS divisor spectra to get ratio spectra of DC and 
that of DS with DC divisor spectra to get the ratio spectra 
of DS. A Δλ=5 was chosen as optimum to minimize the 
background noise. The first order derivative of all the ratio 
spectra of DC and DS were done with Δλ=5.
R D S  a n a l y s i s  w a s  d o n e  u s i n g  U V 1 8 0 0 
spectrophotometer (Shimadzu Corporation, Kyoto, 
Japan) and UV Probe Software, Version 2.42 (Shimadzu 
Corporation, Kyoto, Japan).
Procedure forLC-DAD analysis
DC and DS (1000 µg/mL) stock solutions were 
prepared by dissolving each working standard having 
known purity in 25ml of mobile phase. Different dilutions 
of these stock solutions were taken for preparation of 
linearity curve and working standard solutions for the 
purpose of validation.
For sample solution, 1.0 g of the prepared transdermal 
gel was carefully weighed and transferred to a 50ml 
volumetric flask. 35 mL of the mobile phase were added 
and sonicated for 1hr, allowed to cool to room temperature 
and finally the volume was made up to 50 mL. The final 
solution was centrifuged at 8000 rpm for 25 minutes and 
supernatant was diluted properly to obtain a final solution 
having a concentration of 20 µg/mL of each, DC and DS.
The mobile phase was a mixture of 35% of 0.2 M 
sodium acetate solution and 65% methanol at a flow rate 
of 0.50 mL per minute. The mobile phase and samples 
were filtered through 0.2µm membrane filter before each 
use. DC and DS concentrations were determined using the 
external standard calibration curve.
HPLC was performed by using Waters high pressure 
gradient HPLC module consisting of two Waters 515 pumps 
(Milfold, MA, USA) and 2996 PDA detector (Milfold, MA, 
USA). The data analysis and procurement were carried out 
using Waters Empower 2 software (Milfold, MA, USA).The 
column Atlantis T3 C18 (particle size 5 µm, 4.6 mm internal 
diameter × 250 mm length) was used for the separation 
purpose and kept at room temperature using the detection 
wavelength 257 nm for DC and 274 nm for DS.
Method validation
The analytical method was validated as per ICH 
guidelines. The studied parameters were specificity, 
accuracy, precision, linearity, range, robustness and 
system suitability studies. The linearity of the method was 
established by analyzing standard solutions in triplicate.
To ensure reliability and accuracy of the proposed 
method, recovery studies were carried out by mixing a 
known quantity of the standard solution with the pre-
analyzed samples at three different levels (80%, 100% 
and 120% of assay value) and were reanalyzed using the 
proposed method.
Precision of the method was measured on the basis 
of repeatability. For LC-DAD method the repeatability 
was measured on the basis of six replicate injections 
of the 20µg/ml of each (DC and DS) solutions keeping 
the concentration of one component fixed at each 
concentration of the sample on the same day. The intra-day 
precision was calculated using six injections at the higher 
concentration on the same day. This study was repeated on 
three consecutive days to obtain the inter-day precision. 
The intermediate precision was obtained by triplicate 
injection of the sample solution on three different days.
The RDS method followed the same protocol 
mentioned for the LC-DAD analysis. For RDS the 
scanning range for the experimental solutions was 200-
600 nm.
The limit of detection (LOD) and the limit of 
quantitation (LOQ) were determined using the equations 
presented as follows.
; 
where  denotes standard deviation of Y-intercepts, and S 
denotes slope of the linearity curve
The robustness of the LC-DAD method was 
de t e rmined  by  mak ing  s l i gh t  changes  i n  t he 
chromatographic conditions. The parameter Specificity 
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helps to measure accurately the analyte signal in presence 
of the potent excipients in formulation. The blank gel 
solution was used as placebo solution for this purpose and 
was analyzed by both of the proposed methods.
Statistical Analysis
The statistical analysis was carried out using Sigma 
Plot 10.0 (SSPS Inc., USA) and Microsoft Office Excel 
2010. Each analysis was carried out in three replicates.
RESULTS AND DISCUSSION
Ratio Derivative Spectrum analysis
In RDS both, the standard and the sample solutions 
were scanned between 200 nm to 600 nm. The absorbance 
maxima of zero order spectrums for DC and DS were 
observed at 258 nm and at 275 nm respectively. The 
absorption spectra of DS and DC presented strong 
overlapping over the range of 250 nm-300 nm (Figure 2). 
The zero-order spectrum of the mixture provides accurate 
quantification of DC at 258 nm only from the mixture, but 
not DS. In order to improve accuracy in quantification of 
DS, ratio derivative analysis was carried out.
The concentrations of the drugs were calculated 
from their corresponding regression equations (Equations 
1, 2) measuring the intensity of the signals of the ratio 
derivative spectrum (Figure 3 and 4). Wavelength 304.50 
nm was selected for the quantification of DS and 263.00 
nmwas selected for the quantification of DC in formulation 
containing both (Figure 5 and 6). Measured analytical 
signals at these wavelengths were found to be proportional 
to the concentrations of these drugs.
y = 1.965x + 0.156 for DS Equation 1
y = 3.054x + 0.464 for DC Equation 2
FIGURE 4 - Ratio spectra of DS by DC5.
FIGURE 3 - Ratio spectra of DC by DS6.
FIGURE 2 - Zero order spectrum of DC (blue), DS (red) and 
mixture of DC and DS (black).
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order to study any co-elution. The LC-DAD analysis 
revealed the peak to be pure and spectrally homogenous 
with peak purity angle 0.319 being less than the peak 
purity threshold 0.459 for DS and for DC 0.327 and 0.451 
respectively. The average retention time of DC peak was 
3.81 ± 0.05 minutes (± S.D.; n=3) and for DS was 9.22 
± 0.11 minutes. A reasonable resolution between the DC 
and DS peaks was observed in the sample (Figure 7). The 
peaks were symmetrical and well resolved.
Validation of the developed methods
The  Ra t io  Der iva t ive  method  and  l iqu id 
chromatographic method were validated as per ICH (Q2/
R1) guidelines and the various parameters were evaluated, 
which are presented as follows.
Linearity and sensitivity (LOD and LOQ)
In case of RDS analysis the method was found to be 
linear in the concentration range 1-10 µg/mL for both DC 
and DS with r2 value 0.999 for DS and 0.996 for DC. The 
LOD and LOQ for DC were 0.361 µg/ml and 0.975 µg/ml 
and for DS 0.257 µg/mL and 0.444 µg/mL, respectively 
(Millership, Parker, Donnelly, 2005).
For LC-DAD analysis the linearity concentration 
region was observed in the range of 5.0 to 40.0 µg/mL. 
An area versus concentration curve was drawn with the 
concentration on X- axis and the peak area on the Y-axis. 
The linear regression parameters were slope 99609 and 
Y- intercept 99070 at 95% confidence interval (p<0.0015) 
for DC and slope 44032 and Y- intercept 26445 at 95% 
confidence interval (p<0.0011) for DS. The correlation 
coefficient r2was 0.999 for DC and 0.998 for DS. A 
statistical residual analysis was performed for each point 
of concentration range corresponding to the difference 
between the estimated and the mean concentrations. The 
residual plot analysis demonstrated that the residual values 
were randomly distributed around the zero value. This 
confirms the choice of linear model (Snyder, Kirkland, 
Glajach, 1997).The sensitivity of the method was 
evaluated on the basis of LOD and LOQ values which 
were 1.98 µg/mL and 6.01 µg/mL respectively for DS and 
3.28 µg/mL and 9.95 µg/mL respectively for DC (Table I ).
Precision
For both RDS and HPLC analysis the precision of 
the method was analyzed on the basis of repeatability as 
presented in Table I. The intra-day and inter-day precision 
values were calculated from the linearity curve and the 
observed % RSD value was < 2.0 (Ahuja, Scrypinski, 
2001; Snyder, Kirkland, Glajach, 1997) (Table I). The 
FIGURE 6 - Ratio derivative spectra of DS.
FIGURE 5 – Ratio Derivative spectra of DC.
LC-DAD Analysis
In case of LC-DAD analysis the maximum for 
DC was observed at 257 nm and for DS at 274 nm. The 
chromatogram was subjected to peak purity analysis in 
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obtained intra-day % RSD values were higher than that of 
the inter-day values although both are in acceptable range. 
Therefore the results suggest that both the method is more 
precise in case of inter-day study than the intraday study. 
Accuracy
The accuracy of a method is defined as a percentage 
of systematic error and was calculated as the deviation 
agreement between the measured value and the true 
value (Snyder, Kirkland, Glajach, 1997). In our study, the 
accuracy was determined on the basis of recovery study 
for both the analytical methods.
For RDS analysis RSD% of 0.145 for DC and 
0.526 for DS was observed (Table II) (Millership, Parker, 
Donnelly, 2005). At three different levels – 80%, 100% 
and 120%. Therefore the results established a satisfactory 
level of accuracy.
The analysis results revealed a recovery of 99.50% 
to 100% with a RSD % of 0.45 for DC and 99.00% to 
101.00% for DS with RSD% of 0.90 for LC-DAD analysis 
(Table III). These results also ensured the accuracy of the 
method.
Robustness
The robustness was tested in order to evaluate the 
variation of analytical result due to deliberate changes 
in analytical conditions. The changes in operational 
parameters (change in person) did not lead to significant 
changes in the result. The response determined in the 
robustness test is the percentage of the drug in relation to 
the nominal amount of sample and the percent variation 
between them was 0.96% for DC and 0.95% for DS in 
spectroscopic analysis and 0.97% for DC and 0.98% for 
DS in chromatographic analysis. The results of robustness 
study for both the methods established their acceptability 
(Millership, Parker, Donnelly, 2005).
Specificity
The results obtained from both proposed methods 
for the placebo and the standard solutions were compared. 
The specificity with regard to other co-eluting 
components of DC and DS were separately investigated 
in HPLC. Sufficient resolution between DS and DC 
peak were observed under optimized chromatographic 
conditions (Figure 7). In all cases the purity angle was 
less than the peak purity threshold indicating the absence 
of any co-eluting peaks. The resolution factor between 
the DC and DS peaks in the chromatogram of the sample 
was 4.81 (Table I).
System Suitability
System suitability study was carried out for the 
chromatographic analysis only. The approximate results 
were theoretical plates (N = 12356 for DC and 26359 for 
FIGURE 7 - Representative chromatograms of DC at 257 nm (A) and DS at 274 nm (B), chromatogram of DC from sample 
formulation (C) and DS from sample formulation (D).
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TABLE I - Validation data for the estimation of DC and DS from transdermal gel preparation based on LC-DAD and Ratio derivative 
spectroscopic analysis
Parameters LC-DAD Ratio Derivative Spectroscopy
DC DS DS DC
System suitability  
Retention time (min) 3.80 ± 0.29 9.20 ± 0.69 - -
Capacity factor 1.80 3.90 - -
Resolution - 4.81 - -
USP tailing factor 0.95 0.01 - -
USP theoretical plates 
(N)
12356 26359 - -
Sensitivity  
Limit of detection 
(LOD) (µg/mL)
3.28 1.98 0.25 0.32
Limit of quantitation 
(LOQ (µg/mL)
9.95 6.01 0.44 0.96
Precision 
Intra-day
Repeatability (mg/g of 
gel) (n=6) 
19.96 20.07 20.99 21.05
%RSD 0.98 0.05 1.43 1.03
Inter-day
Mean drug content 
(mg/g of gel)  
(day 1/day 2/day 3) 
(n=3)
19.95/19.78/19.81 19.99/20.11/20.15 20.89/19.99/20.81 21.11/20.96/20.59
Intermediate precision 19.85 20.08 20.56 20.89
(%RSD) (day 1/day 2/
day 3) (n = 6)
1.01/0.56/0.87 0.12/0.09/0.05 0.55/0.43/0.55 0.52/0.55/0.68
TABLEII - Table for accuracy study DC and DS for ratio derivative spectroscopy analysis
Average 
Theoretical 
concentration 
of sample 
solution 
(µg/mL)
Solution 
(%)
Theoretical 
Concentration 
from spiked 
solution 
(µg/mL)
Theoretical 
excess 
amount 
added 
(µg/mL)
Average 
actual 
assay from 
sample 
solution 
(µg/mL)
Assay from 
spiked 
solution 
(µg/mL)
Observed 
excess 
amount 
(µg/mL)
Recovery 
differrence 
(µg/mL)
Accuracy 
(%) %RSD
DC 19.99
80.0 15.99 4.00
20.14
15.90 4.24 0.24 99.45
0.145100 21.99 2.00 21.90 2.08 0.08 99.62
120 23.99 4.00 23.92 4.21 0.21 99.74
DS 20.01
80.0 16.01 4.00
20.03
15.76 4.27 0.27 98.45
0.526100 22.01 2.00 21.89 2.14 0.14 99.50
120 24.01 4.00 23.77 4.14 0.14 99.04
S. B. Mallick, H. Chattopadhyay, A. K. De, S. Datta
Braz. J. Pharm. Sci. 2017;53(2):e15154Page 8 / 10
DS), capacity factor (k =1.80 for DC and 3.90 for DS), 
peak asymmetry or tailing factor (t =0.95 for DC and 0.01 
for DS). The values for these parameters were satisfactory 
in accordance with the literature (Snyder, Kirkland, 
Glajach, 1997) (Table I).
Solution stability
The prepared solution was evaluated after 7 days and 
found to be stable only when kept at 4 °C.
Comparison between UV and HPLC method
Both proposed analytical techniques were compared 
using statistical analysis. 
The F-test was applied to determine whether one 
population is more variable than another in relative 
standard deviations (repeatability). Referring to the table 
of F against 1 degree of freedom (d.f) for between mean 
square and16 d.f for within mean square, we find a value 
4.49 at 5% level of significance. Since the value 1.0003 
for F obtained in the present experiment which is far 
below than the recorded value 4.49, we conclude that the 
difference between the methods is highly insignificant 
(p>0.05).
The t-test was applied to determine whether or not 
there is a statistically significant difference between the 
mean assay values of two proposed methods. The obtained 
results were 0.917 and 1.59, for DC and DS respectively, 
well below the tabled value (2.776) at 95% confidence 
level.
The calculated F-values and t-values were found 
to be less than the critical values at 5% significance level 
(4.49 and 2.776 respectively).
The LOD and LOQ values for both methods 
suggested that the RDS method was more sensitive than 
LC-DAD method. But the regression values helped to 
predict the determination of DC more accurately by LC-
DAD analytical method whereas DS was determined more 
accurately by RDS method. The RDS technique is simpler, 
economic, need lesser time and sufficient samples can be 
done within a day compared to LC-DAD method. But 
LC-DAD analysis method was more precise, specific and 
robust than the RDS method.
Therefore the study represented the fact that the 
RDS method was more accurate and sensitive whereas the 
LC-DAD analysis was more precise. So, the RDS method 
and the chromatographic method can be claimed as unique 
and novel approach for the simultaneous determination 
of these two drugs in a combined dosage form. Thus the 
developed new methods will definitely help in analysis of 
this combined drug product. 
CONCLUSION
The study presents two simple, selective and 
sensitive methods for the quantification of both Diacerein 
and Diclofenac sodium from their combined dosage 
form. The reliability of the methods is reflected from the 
validation parameters. Statistical studies revealed that 
there were no significant differences among the proposed 
methods. However, it appears that the ratio derivative 
spectrophotometric method is more simple, economic 
and accurate compared to the chromatographic method 
although a higher precision can be observed in the latter 
method.
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